The Identifications and Clinical Implications of Cancer Stem Cells in Colorectal Cancer

Torre, 2015, Global cancer statistics, 2012, CA Cancer J Clin, 65, 87, 10.3322/caac.21262 Markowitz, 2009, Molecular origins of cancer: molecular basis of colorectal cancer, N Engl J Med, 361, 2449, 10.1056/NEJMra0804588 Frank, 2010, The therapeutic promise of the cancer stem cell concept, J Clin Invest, 120, 41, 10.1172/JCI41004 Zhou, 2009, Tumour-initiating cells: challenges and opportunities for anticancer drug discovery, Nat Rev Drug Discov, 8, 806, 10.1038/nrd2137 Bruce, 1963, A quantative assay for the number of murine lymphoma cells capable of proliferation in vivo, Nature, 199, 79, 10.1038/199079a0 Brunschwig, 1965, Host resistance to cancer. Clinical experiments by homotransplants, autotransplants and admixture of autologous leucocytes, Ann Surg, 162, 416, 10.1097/00000658-196509000-00011 Hamburger, 1977, Primary bioassay of human tumor stem cells, Science, 197, 461, 10.1126/science.560061 Islam, 2015, Cancer stem cell: fundamental experimental pathological concepts and updates, Exp Mol Pathol, 98, 184, 10.1016/j.yexmp.2015.02.002 Papailiou, 2011, Stem cells in colon cancer. A new era in cancer theory begins, Int J Colorectal Dis, 26, 1, 10.1007/s00384-010-1022-6 Abdul Khalek, 2010, Colon cancer stem cells, Gastrointest Cancer Res, S16 Islam, 2015, Translational potential of cancer stem cells: a review of the detection of cancer stem cells and their roles in cancer recurrence and cancer treatment, Exp Cell Res, 335, 135, 10.1016/j.yexcr.2015.04.018 Prince, 2007, Identification of a subpopulation of cellswith cancer stem cell properties in head and neck squamous cell carcinoma, Proc Natl Acad Sci U S A, 104, 973, 10.1073/pnas.0610117104 Singh, 2004, Cancer stem cells in nervous system tumors, Oncogene, 23, 7267, 10.1038/sj.onc.1207946 Al-Hajj, 2003, Prospective identification of tumorigenic breast cancer cells, Proc Natl Acad Sci U S A, 100, 3983, 10.1073/pnas.0530291100 O'Brien, 2007, A human colon cancer cell capable of initiating tumour growth in immunodeficient mice, Nature, 445, 106, 10.1038/nature05372 Lapidot, 1994, A cell initiating human acute myeloid leukaemia after transplantation into SCID mice, Nature, 367, 645, 10.1038/367645a0 Jiang, 2009, Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer, Mol Cancer Res, 7, 330, 10.1158/1541-7786.MCR-08-0393 Visvader, 2008, Cancer stem cells in solid tumours: accumulating evidence and unresolved questions, Nat Rev Cancer, 8, 755, 10.1038/nrc2499 Bissell, 2005, Context, tissue plasticity, and cancer: are tumor stem cells also regulated by the microenvironment?, Cancer Cell, 7, 17 Qiao, 2012, Epithelial-mesenchymal transition and mesenchymal-epithelial transition are essential for the acquisition of stem cell properties in hTERT-immortalised oral epithelial cells, Biol Cell, 104, 476, 10.1111/boc.201100077 Kong, 2011, Cancer stem cells and epithelial-to-mesenchymal transition (EMT)-phenotypic cells: are they cousins or twins?, Cancers (Basel), 3, 716, 10.3390/cancers30100716 Mitsui, 2003, The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells, Cell, 113, 631, 10.1016/S0092-8674(03)00393-3 Matsuoka, 2012, Role of the stemness factors sox2, oct3/4, and nanog in gastric carcinoma, J Surg Res, 174, 130, 10.1016/j.jss.2010.11.903 Meng, 2010, Over-expression of Nanog predicts tumor progression and poor prognosis in colorectal cancer, Cancer Biol Ther, 9, 295, 10.4161/cbt.9.4.10666 Avery, 2006, The regulation of self-renewal in human embryonic stem cells, Stem Cells Dev, 15, 729, 10.1089/scd.2006.15.729 Rodda, 2005, Transcriptional regulation of nanog by OCT4 and SOX2, J Biol Chem, 280, 24731, 10.1074/jbc.M502573200 Padín-Iruegas, 2013, Prognostic value of changes in the expression of stem cell markers in the peripheral blood of patients with colon cancer, Oncol Rep, 29, 2467, 10.3892/or.2013.2368 Avilion, 2003, Multipotent cell lineages in early mouse development depend on SOX2 function, Genes Dev, 17, 126, 10.1101/gad.224503 Sarkar, 2013, The sox family of transcription factors: versatile regulators of stem and progenitor cell fate, Cell Stem Cell, 12, 15, 10.1016/j.stem.2012.12.007 Takahashi, 2006, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell, 126, 663, 10.1016/j.cell.2006.07.024 Basu-Roy, 2012, Sox2 maintains self-renewal of tumor-initiating cells in osteosarcomas, Oncogene, 31, 2270, 10.1038/onc.2011.405 Cai, 2016, Regulation of tumorigenesis in oral epithelial cells by defined reprogramming factors Oct4 and Sox2, Oncol Rep, 36, 651, 10.3892/or.2016.4851 Saiki, 2009, Comprehensive analysis of the clinical significance of inducing pluripotent stemness-related gene expression in colorectal cancer cells, Ann Surg Oncol, 16, 2638, 10.1245/s10434-009-0567-5 Ong, 2010, CD133 expression predicts for non-response to chemotherapy in colorectal cancer, Mod Pathol, 23, 450, 10.1038/modpathol.2009.181 Saigusa, 2009, Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy, Ann Surg Oncol, 16, 3488, 10.1245/s10434-009-0617-z de Lau, 2012, The R-spondin protein family, Genome Biol, 13, 242, 10.1186/gb-2012-13-3-242 Wu, 2012, Lgr5 is a potential marker of colorectal carcinoma stem cells that correlates with patient survival, World J Surg Oncol, 10, 244, 10.1186/1477-7819-10-244 Schepers, 2012, Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas, Science, 337, 730, 10.1126/science.1224676 Merlos-Suárez, 2011, The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse, Cell Stem Cell, 8, 511, 10.1016/j.stem.2011.02.020 Takahashi, 2011, Significance of Lgr5(+ve) cancer stem cells in the colon and rectum, Ann Surg Oncol, 18, 1166, 10.1245/s10434-010-1373-9 Kemper, 2012, Mutations in the Ras-Raf Axis underlie the prognostic value of CD133 in colorectal cancer, Clin Cancer Res, 18, 3132, 10.1158/1078-0432.CCR-11-3066 Li, 2009, Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIB, J Transl Med, 7, 56, 10.1186/1479-5876-7-56 Rowehl, 2014, Establishment of highly tumorigenic human colorectal cancer cell line (CR4) with properties of putative cancer stem cells, PLoS One, 9, e99091, 10.1371/journal.pone.0099091 Sahlberg, 2014, Evaluation of cancer stem cell markers CD133, CD44, CD24: association with AKT isoforms and radiation resistance in colon cancer cells, PLoS One, 9, e94621, 10.1371/journal.pone.0094621 Hynes, 1992, Integrins: versatility, modulation, and signaling in cell adhesion, Cell, 69, 11, 10.1016/0092-8674(92)90115-S Fujimoto, 2002, Identification and isolation of candidate human colonic clonogenic cells based on cell surface integrin expression, Gastroenterology, 123, 1941, 10.1053/gast.2002.37065 Vermeulen, 2008, Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity, Proc Natl Acad Sci U S A, 105, 13427, 10.1073/pnas.0805706105 Zou, 2011, Proteome of human colon cancer stem cells: a comparative analysis, World J Gastroenterol, 17, 1276, 10.3748/wjg.v17.i10.1276 Crabb, 2004, Overview of the role of alcohol dehydrogenase and aldehyde dehydrogenase and their variants in the genesis of alcohol-related pathology, Proc Nutr Soc, 63, 49, 10.1079/PNS2003327 Subramaniam, 2010, Cancer stem cells: a novel paradigm for cancer prevention and treatment, Mini Rev Med Chem, 10, 359, 10.2174/138955710791330954 Carpentino, 2009, Aldehyde dehydrogenase-expressing colon stem cells contribute to tumorigenesis in the transition from colitis to cancer, Cancer Res, 69, 8208, 10.1158/0008-5472.CAN-09-1132 Langan, 2012, A pilot study assessing the potential role of non-CD133 colorectal cancer stem cells as biomarkers, J Cancer, 3, 231 Lugli, 2010, Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer, Br J Cancer, 103, 382, 10.1038/sj.bjc.6605762 Patriarca, 2012, Epithelial cell adhesion molecule expression (CD326) in cancer: a short review, Cancer Treat Rev, 38, 68, 10.1016/j.ctrv.2011.04.002 Litvinov, 1994, Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule, J Cell Biol, 125, 437, 10.1083/jcb.125.2.437 Roy, 2015, LNA aptamer based multi-modal, Fe3O4-saturated lactoferrin (Fe3O4-bLf) nanocarriers for triple positive (EpCAM, CD133, CD44) colon tumor targeting and NIR, MRI and CT imaging, Biomaterials, 71, 84, 10.1016/j.biomaterials.2015.07.055 Spring, 1988, The Ina and Inb blood group antigens are located on a glycoprotein of 80,000 MW (the CDw44 glycoprotein) whose expression is influenced by the In(Lu) gene, Immunology, 64, 37 Dalerba, 2007, Phenotypic characterization of human colorectal cancer stem cells, Proc Natl Acad Sci U S A, 104, 10158, 10.1073/pnas.0703478104 Du, 2008, CD44 is of functional importance for colorectal cancer stem cells, Clin Cancer Res, 14, 6751, 10.1158/1078-0432.CCR-08-1034 Wang, 2012, Silibinin suppresses the maintenance of colorectal cancer stem-like cells by inhibiting PP2A/AKT/mTOR pathways, J Cell Biochem, 113, 1733 Dallas, 2012, Divergent roles of CD44 and carcinoembryonic antigen in colon cancer metastasis, FASEB J, 26, 2648, 10.1096/fj.12-203786 Ylagan, 2000, Cd44: a marker of squamous differentiation in adenosquamous neoplasms, Arch Pathol Lab Med, 124, 212, 10.5858/2000-124-0212-C Lehmann, 1989, MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamily, Proc Natl Acad Sci U S A, 86, 9891, 10.1073/pnas.86.24.9891 Weidle, 2010, ALCAM/CD166: cancer-related issues, Cancer Genomics Proteomics, 7, 231 Mărgaritescu, 2014, CD133/CD166/Ki-67 triple immunofluorescence assessment for putative cancer stem cells in colon carcinoma, J Gastrointestin Liver Dis, 23, 161, 10.15403/jgld.2014.1121.232.cm1 Dalerba, 2007, Phenotypic characterization of human colorectal cancer stem cells, Proc Natl Acad Sci U S A, 104, 10158, 10.1073/pnas.0703478104 Pro, 2004, CD26/dipeptidyl peptidase IV and its role in cancer, Histol Histopathol, 19, 1345 Thompson, 2007, CD26/dipeptidyl peptidase IV as a novel therapeutic target for cancer and immune disorders, Mini Rev Med Chem, 7, 253, 10.2174/138955707780059853 Pang, 2010, A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer, Cell Stem Cell, 6, 603, 10.1016/j.stem.2010.04.001 Dalerba, 2007, Cancer stem cells and tumor metastasis: first steps into uncharted territory, Cell Stem Cell, 1, 241, 10.1016/j.stem.2007.08.012 Fitzgerald, 2014, The impact of aldehyde dehydrogenase 1 expression on prognosis for metastatic colon cancer, J Surg Res, 192, 82, 10.1016/j.jss.2014.05.054 Deng, 2014, ALDH1 is an independent prognostic factor for patients with stages II-III rectal cancer after receiving radiochemotherapy, Br J Cancer, 110, 430, 10.1038/bjc.2013.767 Goossens-Beumer, 2014, Clinical prognostic value of combined analysis of Aldh1, Survivin, and EpCAM expression in colorectal cancer, Br J Cancer, 110, 2935, 10.1038/bjc.2014.226 Kahlert, 2012, Expression analysis of aldehyde dehydrogenase 1A1 (ALDH1A1) in colon and rectal cancer in association with prognosis and response to chemotherapy, Ann Surg Oncol, 19, 4193, 10.1245/s10434-012-2518-9 Chen, 2006, P-selectin mediates adhesion of leukocytes, platelets, and cancer cells in inflammation, thrombosis, and cancer growth and metastasis, Arch Immunol Ther Exp (Warsz), 54, 75, 10.1007/s00005-006-0010-6 Pirruccello, 1986, The human B cell-associated antigen CD24 is a single chain sialoglycoprotein, J Immunol, 136, 3779, 10.4049/jimmunol.136.10.3779 Fischer, 1990, Signal transduction in lymphocytic and myeloid cells via CD24, a new member of phosphoinositol-anchored membrane molecules, J Immunol, 144, 638, 10.4049/jimmunol.144.2.638 Sammar, 1994, Heat-stable antigen (CD24) as ligand for mouse P-selectin, Int Immunol, 6, 1027, 10.1093/intimm/6.7.1027 Kristiansen, 2004, CD24 expression is a significant predictor of PSA relapse and poor prognosis in low grade or organ confined prostate cancer, Prostate, 58, 183, 10.1002/pros.10324 Kristiansen, 2002, CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival, Am J Pathol, 161, 1215, 10.1016/S0002-9440(10)64398-2 Kristiansen, 2003, CD24 expression is a new prognostic marker in breast cancer, Clin Cancer Res, 9, 4906 Darwish, 2004, Prognostic significance of CD24 expression in gastric carcinoma, Cancer Res Treat, 36, 298, 10.4143/crt.2004.36.5.298 Vaiopoulos, 2012, Colorectal cancer stem cells, Stem Cells, 30, 363, 10.1002/stem.1031 Weichert, 2005, Cytoplasmic CD24 expression in colorectal cancer independently correlates with shortened patient survival, Clin Cancer Res, 11, 6574, 10.1158/1078-0432.CCR-05-0606 Choi, 2009, Cancer stem cell markers CD133 and CD24 correlate with invasiveness and differentiation in colorectal adenocarcinoma, World J Gastroenterol, 15, 2258, 10.3748/wjg.15.2258 Seo, 2015, Prognostic implications of adhesion molecule expression in colorectal cancer, Int J Clin Exp Pathol, 8, 4148 Ahmed, 2009, CD24 shows early upregulation and nuclear expression but is not a prognostic marker in colorectal cancer, J Clin Pathol, 62, 1117, 10.1136/jcp.2009.069310 Huh, 2009, Expression of standard CD44 in human colorectal carcinoma: association with prognosis, Pathol Int, 59, 241, 10.1111/j.1440-1827.2009.02357.x Wielenga, 1998, CD44 splice variants as prognostic markers in colorectal cancer, Scand J Gastroenterol, 33, 82, 10.1080/00365529850166257 Ngan, 2007, A multivariate analysis of adhesion molecules expression in assessment of colorectal cancer, J Surg Oncol, 95, 652, 10.1002/jso.20638 Morrin, 2002, CD44v6 is not relevant in colorectal tumour progression, Int J Colorectal Dis, 17, 30, 10.1007/s003840100335 Jing, 2015, Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastases, Int J Oncol, 46, 1582, 10.3892/ijo.2015.2844 Schneider, 2012, Characterization of colon cancer cells: a functional approach characterizing CD133 as a potential stem cell marker, BMC Cancer, 12, 96, 10.1186/1471-2407-12-96 Lin, 2011, STAT3 signaling pathway is necessary for cell survival and tumorsphere forming capacity in ALDH+/CD133+ stem cell-like human colon cancer cells, Biochem Biophys Res Commun, 416, 246, 10.1016/j.bbrc.2011.10.112 Fang, 2010, Expansion of CD133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery, Br J Cancer, 102, 1265, 10.1038/sj.bjc.6605610 Jao, 2012, Cytoplasmic CD133 expression is a reliable prognostic indicator of tumor regression after neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer, Ann Surg Oncol, 19, 3432, 10.1245/s10434-012-2394-3 Pilati, 2012, Prognostic value of putative circulating cancer stem cells in patients undergoing hepatic resection for colorectal liver metastasis, Ann Surg Oncol, 19, 402, 10.1245/s10434-011-2132-2 Horst, 2008, CD133 expression is an independent prognostic marker for low survival in colorectal cancer, Br J Cancer, 99, 1285, 10.1038/sj.bjc.6604664 Horst, 2009, The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer, J Pathol, 219, 427, 10.1002/path.2597 Kojima, 2008, Immunohistochemical detection of CD133 expression in colorectal cancer: a clinicopathological study, Cancer Sci, 99, 1578, 10.1111/j.1349-7006.2008.00849.x Lin, 2007, Elevated circulating endothelial progenitor marker CD133 messenger RNA levels predict colon cancer recurrence, Cancer, 110, 534, 10.1002/cncr.22774 Iinuma, 2011, Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer, J Clin Oncol, 29, 1547, 10.1200/JCO.2010.30.5151 Gazzaniga, 2010, Molecular markers in circulating tumour cells from metastatic colorectal cancer patients, J Cell Mol Med, 14, 2073, 10.1111/j.1582-4934.2010.01117.x Tachezy, 2012, Activated leukocyte cell adhesion molecule (CD166)–its prognostic power for colorectal cancer patients, J Surg Res, 177, e15, 10.1016/j.jss.2012.02.013 Mezzanzanica, 2008, Subcellular localization of activated leukocyte cell adhesion molecule is a molecular predictor of survival in ovarian carcinoma patients, Clin Cancer Res, 14, 1726, 10.1158/1078-0432.CCR-07-0428 Klein, 2007, Increased expression of stem cell markers in malignant melanoma, Mod Pathol, 20, 102, 10.1038/modpathol.3800720 Burkhardt, 2006, Cytoplasmic overexpression of ALCAM is prognostic of disease progression in breast cancer, J Clin Pathol, 59, 403, 10.1136/jcp.2005.028209 Verma, 2005, MEMD/ALCAM: a potential marker for tumor invasion and nodal metastasis in esophageal squamous cell carcinoma, Oncology, 68, 462, 10.1159/000086989 Weichert, 2004, ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival, J Clin Pathol, 57, 1160, 10.1136/jcp.2004.016238 Tomita, 2003, Activated Leukocyte Cell Adhesion Molecule (ALCAM) expression is associated with a poor prognosis for bladder cancer patients, Urooncology, 3, 121, 10.1080/15610950310001632322 Sim, 2014, P21 and CD166 as predictive markers of poor response and outcome after fluorouracil-based chemoradiotherapy for the patients with rectal cancer, BMC Cancer, 14, 241, 10.1186/1471-2407-14-241 Spizzo, 2011, EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis, J Clin Pathol, 64, 415, 10.1136/jcp.2011.090274 Went, 2004, Frequent EpCam protein expression in human carcinomas, Hum Pathol, 35, 122, 10.1016/j.humpath.2003.08.026 Herlyn, 1979, Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies, Proc Natl Acad Sci U S A, 76, 1438, 10.1073/pnas.76.3.1438 Zhou, 2015, Expression of EpCAM and Wnt/β-catenin in human colon cancer, Genet Mol Res, 14, 4485, 10.4238/2015.May.4.6 van der Gun, 2010, EpCAM in carcinogenesis: the good, the bad or the ugly, Carcinogenesis, 31, 1913, 10.1093/carcin/bgq187 Gosens, 2007, Loss of membranous Ep-CAM in budding colorectal carcinoma cells, Mod Pathol, 20, 221, 10.1038/modpathol.3800733 Uchida, 2010, Overexpression of leucine-rich repeat-containing G protein-coupled receptor 5 in colorectal cancer, Cancer Sci, 101, 1731, 10.1111/j.1349-7006.2010.01571.x Liu, 2014, Over-expression of LGR5 correlates with poor survival of colon cancer in mice as well as in patients, Neoplasma, 61, 177, 10.4149/neo_2014_016 Hsu, 2013, Overexpression of Lgr5 correlates with resistance to 5-FU-based chemotherapy in colorectal cancer, Int J Colorectal Dis, 28, 1535, 10.1007/s00384-013-1721-x Saigusa, 2013, Significant correlation between LKB1 and LGR5 gene expression and the association with poor recurrence-free survival in rectal cancer after preoperative chemoradiotherapy, J Cancer Res Clin Oncol, 139, 131, 10.1007/s00432-012-1308-x Han, 2015, LGR5, a relevant marker of cancer stem cells, indicates a poor prognosis in colorectal cancer patients: a meta-analysis, Clin Res Hepatol Gastroenterol, 39, 267, 10.1016/j.clinre.2014.07.008 Xu, 2012, Nanog: a potential biomarker for liver metastasis of colorectal cancer, Dig Dis Sci, 57, 2340, 10.1007/s10620-012-2182-8 Lundberg, 2014, SOX2 expression is regulated by BRAF and contributes to poor patient prognosis in colorectal cancer, PLoS One, 9, e101957, 10.1371/journal.pone.0101957 Islam, 2015, Cancer stem cells in oesophageal squamous cell carcinoma: identification, prognostic and treatment perspectives, Crit Rev Oncol Hematol, 96, 9, 10.1016/j.critrevonc.2015.04.007 Vermeulen, 2012, The developing cancer stem-cell model: clinical challenges and opportunities, Lancet Oncol, 13, e83, 10.1016/S1470-2045(11)70257-1 Garvalov, 2011, Cancer stem cells: a new framework for the design of tumor therapies, J Mol Med (Berl), 89, 95, 10.1007/s00109-010-0685-3 Todaro, 2010, Colon cancer stem cells: promise of targeted therapy, Gastroenterology, 138, 2151, 10.1053/j.gastro.2009.12.063 Damek-Poprawa, 2011, Targeted inhibition of CD133+ cells in oral cancer cell lines, J Dent Res, 90, 638, 10.1177/0022034510393511 Dou, 2010, Emerging strategies for the identification and targeting of cancer stem cells, Tumour Biol, 31, 243, 10.1007/s13277-010-0023-y Park, 2012, Berberine inhibits human colon cancer cell migration via AMP-activated protein kinase-mediated downregulation of integrin β1 signaling, Biochem Biophys Res Commun, 426, 461, 10.1016/j.bbrc.2012.08.091 Dallas, 2009, Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition, Cancer Res, 69, 1951, 10.1158/0008-5472.CAN-08-2023 Sagiv, 2008, Targeting CD24 for treatment of colorectal and pancreatic cancer by monoclonal antibodies or small interfering RNA, Cancer Res, 68, 2803, 10.1158/0008-5472.CAN-07-6463 Todaro, 2007, Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4, Cell Stem Cell, 1, 389, 10.1016/j.stem.2007.08.001 Punt, 2002, Edrecolomab alone or in combination with fluorouracil and folinic acid in the adjuvant treatment of stage III colon cancer: a randomised study, Lancet, 360, 671, 10.1016/S0140-6736(02)09836-7 Todaro, 2008, IL-4-mediated drug resistance in colon cancer stem cells, Cell Cycle, 7, 309, 10.4161/cc.7.3.5389 Riethmüller, 1994, Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group, Lancet, 343, 1177, 10.1016/S0140-6736(94)92398-1 Kanwar, 2011, Difluorinated-curcumin (CDF): a novel curcumin analog is a potent inhibitor of colon cancer stem-like cells, Pharm Res, 28, 827, 10.1007/s11095-010-0336-y Liu, 2013, Cisplatin selects for multidrug-resistant CD133+ cells in lung adenocarcinoma by activating Notch signaling, Cancer Res, 73, 406, 10.1158/0008-5472.CAN-12-1733 Peitzsch, 2013, Discovery of the cancer stem cell related determinants of radioresistance, Radiother Oncol, 108, 378, 10.1016/j.radonc.2013.06.003 van Es, 2005, Notch and Wnt inhibitors as potential new drugs for intestinal neoplastic disease, Trends Mol Med, 11, 496, 10.1016/j.molmed.2005.09.008 Green, 2001, Beta-catenin antisense treatment decreases beta-catenin expression and tumor growth rate in colon carcinoma xenografts, J Surg Res, 101, 16, 10.1006/jsre.2001.6241 van de Wetering, 2002, The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells, Cell, 111, 241, 10.1016/S0092-8674(02)01014-0 Chen, 2009, Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer, Nat Chem Biol, 5, 100, 10.1038/nchembio.137